Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01723787 · ClinicalTrials.gov registry record
Genetic Studies in Patients and Families With Infantile Spasms
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 63
- Enrollment target
NCT01723787 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 63 participants.
The verdict
NCT01723787 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
Infantile spasms (IIS), a characteristic epilepsy syndrome of infancy with often catastrophic developmental consequences, is known in some patients to have many different genetic, metabolic and structural etiologies. However, for most patients IIS is the only presenting clinical feature and the specific cause is unknown. Only two FDA approved pharmacologic treatments for IIS exist, Adrenocorticotropic hormone (ACTH) and vigabatrin. While vigabatrin may be the treatment of choice for Tuberous Sclerosis as a cause for IS, ACTH is the treatment of choice for all others. Unfortunately, a substantial number of patients may still not respond to ACTH and there is no a priori way that suggests which patients may be responders. This has led to the following key questions: Can novel genetic analyses determine known genetic causes of IS with greater efficiency (more timely and cost-effective)? Can novel genetic analyses determine previously unknown disease modifying genes that predispose individuals to develop IS? Can novel genetic analyses elaborate genes and gene polymorphisms that favor ACTH responsiveness? Do these polymorphisms suggest strategies to improve ACTH responsiveness?
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2013-03 |
| Est. Completion | 2018-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01723787
The ClinicalTrials.gov registry entry for NCT01723787 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01723787 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01723787 about?
NCT01723787 is a clinical study titled "Genetic Studies in Patients and Families With Infantile Spasms". Infantile spasms (IIS), a characteristic epilepsy syndrome of infancy with often catastrophic developmental consequences, is known in some patients to have many different genetic, metabolic and structural etiologies. However, for most patients IIS is the only presenting clinical feature and the spec...
What is the current status of trial NCT01723787?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2013-03. Estimated completion is 2018-11-30.
Who is sponsoring clinical trial NCT01723787?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.